These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression. Wang D, Yang X, Chen Y, Gong K, Yu M, Gao Y, Wu X, Hu H, Liao C, Han J, Duan Y. J Biol Chem; 2020 Nov 20; 295(47):15870-15882. PubMed ID: 32913121 [Abstract] [Full Text] [Related]
3. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice. Sun L, Yang X, Li Q, Zeng P, Liu Y, Liu L, Chen Y, Yu M, Ma C, Li X, Li Y, Zhang R, Zhu Y, Miao QR, Han J, Duan Y. Arterioscler Thromb Vasc Biol; 2017 Jul 20; 37(7):1290-1300. PubMed ID: 28546220 [Abstract] [Full Text] [Related]
7. Black Raspberry Extract Enhances LDL Uptake in HepG2 Cells by Suppressing PCSK9 Expression to Upregulate LDLR Expression. Song KH, Kim YH, Im AR, Kim YH. J Med Food; 2018 Jun 20; 21(6):560-567. PubMed ID: 29569973 [Abstract] [Full Text] [Related]
9. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9. Jang HD, Lee SE, Yang J, Lee HC, Shin D, Lee H, Lee J, Jin S, Kim S, Lee SJ, You J, Park HW, Nam KY, Lee SH, Park SW, Kim JS, Kim SY, Kwon YW, Kwak SH, Yang HM, Kim HS. Eur Heart J; 2020 Jan 07; 41(2):239-252. PubMed ID: 31419281 [Abstract] [Full Text] [Related]
11. Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor). Ben Djoudi Ouadda A, Gauthier MS, Susan-Resiga D, Girard E, Essalmani R, Black M, Marcinkiewicz J, Forget D, Hamelin J, Evagelidis A, Ly K, Day R, Galarneau L, Corbin F, Coulombe B, Çaku A, Tagliabracci VS, Seidah NG. Arterioscler Thromb Vasc Biol; 2019 Oct 07; 39(10):1996-2013. PubMed ID: 31553664 [Abstract] [Full Text] [Related]
12. Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells. Yang X, Zhang J, Chen L, Wu Q, Yu C. Exp Cell Res; 2018 May 15; 366(2):152-160. PubMed ID: 29548750 [Abstract] [Full Text] [Related]
13. Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by transcriptional regulation of LDLR via SREBP2. Chae HS, Pel P, Cho J, Kim YM, An CY, Huh J, Choi YH, Kim J, Chin YW. J Ethnopharmacol; 2021 Oct 05; 278():114265. PubMed ID: 34111537 [Abstract] [Full Text] [Related]
15. β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells. Starr AE, Lemieux V, Noad J, Moore JI, Dewpura T, Raymond A, Chrétien M, Figeys D, Mayne J. FEBS J; 2015 Jul 05; 282(14):2682-96. PubMed ID: 25913303 [Abstract] [Full Text] [Related]
20. Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other. Butkinaree C, Canuel M, Essalmani R, Poirier S, Benjannet S, Asselin MC, Roubtsova A, Hamelin J, Marcinkiewicz J, Chamberland A, Guillemot J, Mayer G, Sisodia SS, Jacob Y, Prat A, Seidah NG. J Biol Chem; 2015 Jul 24; 290(30):18609-20. PubMed ID: 26085104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]